Search Results
Test Catalog
HGNA - Overview: Mercury, Nails
Detecting mercury exposure in nail specimens
APOL1 - Overview: APOL1 Genotype, Varies
Determining an individual's APOL1 genotype This test is not useful for clinical management of individuals with APOL1 risk genotypes. This test alone is not useful for determining eligibility for donation or receipt of kidney...
HIVDS - Overview: HIV-1 and HIV-2 Antigen and Antibody Diagnostic Evaluation, Serum
Detecting HIV-1 and HIV-2 infection in symptomatic patients older than 2 years Follow-up testing of symptomatic individuals with reactive rapid HIV test results This test should not be used as a screening or confirmatory test for blood...
THYRP - Overview: Hereditary Thyroid Cancer Panel, Varies
Evaluating patients with a personal or family history suggestive of a hereditary thyroid cancer syndrome Establishing a diagnosis of a hereditary thyroid cancer syndrome, allowing for targeted surveillance based on associated...
H2BR - Overview: HER2 Amplification Associated with Breast Cancer, FISH, Tissue
A predictive marker for patients with both node-positive or node-negative primary and metastatic breast cancer Patients with HER2 amplification that may be candidates for therapies targeting the human epidermal growth factor receptor 2...
HVCOP - Overview: HIV-1 and HIV-2 Antigen and Antibody Routine Screen, Plasma
Screening for HIV-1 and HIV-2 infection in nonsymptomatic, nonpregnant individuals older than 2 years This test should not be used as a screening or confirmatory test for blood donor specimens.
PHI11 - Overview: Prostate Health Index Reflex, Serum
As an aid in distinguishing prostate cancer from benign prostatic conditions in men aged 50 years and older with total PSA between 4.0 and 10.0 ng/mL and digital rectal examination findings that are not suspicious for cancer
Providing a genetic evaluation for patients with a personal or family history suggestive of recessive congenital methemoglobinemia Genotype confirmation of borderline cytochrome b5 reductase (methemoglobin reductase: METR) enzyme activity...
DRV1 - Overview: Dilute Russell's Viper Venom Time (DRVVT), Plasma
Detecting and confirming or helping to exclude the presence of lupus anticoagulants (LA) Identifying LA that do not prolong the activated partial thromboplastin time (APTT) Evaluating unexplained prolongation of the APTT or prothrombin...
DRVI1 - Overview: Dilute Russell's Viper Venom Time (DRVVT), with Reflex, Plasma
Detecting and confirming or helping to exclude the presence of lupus anticoagulants (LA) Identifying LA that do not prolong the activated partial thromboplastin time (APTT) Evaluating unexplained prolongation of the APTT or prothrombin...
G6PD1 - Overview: Glucose 6-Phosphate Dehydrogenase Enzyme Activity, Blood
Evaluation of individuals with episodic or chronic Coombs-negative nonspherocytic hemolytic anemia Rapid testing to assess glucose 6-phosphate dehydrogenase (G6PD) enzyme capacity prior to rasburicase or other therapies that may cause...
LYNCP - Overview: Lynch Syndrome Panel, Varies
Establishing a diagnosis of Lynch syndrome or constitutional mismatch repair deficiency allowing for targeted cancer surveillance based on associated risks Identifying MLH1, MSH2, MSH6, PMS2, or EPCAM variants to allow for predictive...
MPSWB - Overview: Mucopolysaccharidosis, Blood
Supporting the biochemical diagnosis of mucopolysaccharidoses type I, II, III, IV, or VI Quantification of heparan sulfate, dermatan sulfate, and keratan sulfate in whole blood specimens
MPSBS - Overview: Mucopolysaccharidosis, Blood Spot
Supporting the biochemical diagnosis of mucopolysaccharidoses types I, II, III, IV, or VI Quantification of heparan sulfate, dermatan sulfate, and keratan sulfate in dried blood spot specimens
ASNA - Overview: Arsenic, Nails
Detection of nonacute arsenic exposure in nail specimens
HGHAR - Overview: Mercury, Hair
Detecting mercury exposure in hair specimens
Detecting lead exposure using nail specimens
HGOU - Overview: Mercury Occupational Exposure, Random, Urine
Detecting mercury toxicity due to occupational exposure in random urine specimens
ASHA - Overview: Arsenic, Hair
Detection of nonacute arsenic exposure in hair specimens
Determining iodine overload using serum specimens Monitoring iodine levels in individuals taking iodine-containing drugs
CZPS - Overview: Clonazepam and 7-Aminoclonazepam, Serum
Assessing patient compliance Monitoring for appropriate therapeutic level Assessing clonazepam toxicity
CDP - Overview: Chlordiazepoxide and Metabolite, Serum
Monitoring chlordiazepoxide therapy Assessing toxicity
CDOMB - Overview: Cadmium for Occupational Monitoring, Blood
Detecting exposure to cadmium, a toxic heavy metal, as a part of occupational monitoring
MDNS - Overview: Methadone and Metabolites, Serum
Compliance monitoring of methadone Assessment of methadone toxicity
QUIN - Overview: Quinidine, Serum
Assessing and adjusting quinidine dosage for optimal therapeutic level Assessing quinidine toxicity
PERAM - Overview: Perampanel, Serum
Monitoring serum concentration of perampanel, in specific clinical conditions (ie, severe kidney impairment, mild to moderate hepatic impairment, and end-stage kidney disease) Assessing compliance Assessing potential toxicity
SEWB - Overview: Selenium, Blood
Assessment of tissue stores of selenium
CDB - Overview: Cadmium, Blood
Detecting exposure to cadmium, a toxic heavy metal
DIA - Overview: Diazepam and Nordiazepam, Serum
Assessing compliance Monitoring for appropriate therapeutic level Assessing diazepam toxicity
Detecting lead exposure using hair specimens
PBOU - Overview: Lead Occupational Exposure, Random, Urine
Detecting clinically significant lead exposure due to occupational exposure in random urine specimens This test is not a substitute for blood lead screening.
TRSF - Overview: Transferrin, Serum
Evaluation of iron overload diseases Evaluation of iron deficiency as a cause of anemia
ETGL - Overview: Ethylene Glycol, Serum
Confirming and monitoring ethylene glycol toxicity
HMDB - Overview: Heavy Metals Screen with Demographics, Blood
Detecting exposure to arsenic, lead, cadmium, and mercury
CFSMN - Overview: Cystic Fibrosis and Spinal Muscular Atrophy Carrier Screen Panel, Varies
Reproductive risk refinement via carrier screening for individuals in the general population for cystic fibrosis (CF) and spinal muscular atrophy (SMA). Reproductive risk refinement via carrier screening for individuals with a family...
BRTP - Overview: Rapid Hereditary Breast Cancer Treatment Decision Panel, Varies
Establishing a diagnosis of a hereditary breast cancer syndrome allowing for surgical and management decision making Determining therapeutic eligibility with poly (adenosine diphosphate-ribose) polymerase inhibitors based on certain gene...
MCSRC - Overview: MayoComplete Comprehensive Sarcoma Panel, Next-Generation Sequencing, Tumor
Primarily for identifying mutations that help in the diagnosis of specific soft tissue and bone tumors (sarcoma) Secondarily for identifying mutations that have therapeutic or prognostic significance Assessing microsatellite instability...
MPSQU - Overview: Mucopolysaccharides Quantitative, Random, Urine
Supporting the biochemical diagnosis of one of the mucopolysaccharidoses: types I, II, III, IV, VI, or VII
BIWB - Overview: Bismuth, Blood
Determining bismuth toxicity
BRUTA - Overview: Brucella Total Antibody Confirmation, Agglutination, Serum
Diagnosis of brucellosis
CLD18 - Overview: Claudin 18 (CLDN18) (43-14A), Semi-Quantitative Immunohistochemistry, Manual
Identification of tumor cells expressing claudin 18 As an aid in screening patients who may be eligible for VYLOY (zolbetuximab) treatment
HYDMU - Overview: Hydromorphone Confirmation, Random, Urine
Detection and quantification of hydromorphone in urine
HYDCU - Overview: Hydrocodone with Metabolite Confirmation, Random, Urine
Detection and quantification of hydrocodone, norhydrocodone, and hydromorphone in urine
ITCON - Overview: Itraconazole, Serum
Verifying systemic absorption of orally administered itraconazole Patients with life-threatening fungal infections Patients considered at risk for poor absorption or rapid clearance of itraconazole
GABA - Overview: Gabapentin, Serum
Monitoring serum gabapentin concentrations Assessing compliance Adjusting dosage in patients
NOTRP - Overview: Nortriptyline, Serum
Monitoring nortriptyline concentration during therapy Evaluating potential nortriptyline toxicity May aid in evaluating patient compliance
HGCU - Overview: Mercury/Creatinine Ratio, Random, Urine
Detecting mercury toxicity using random urine specimens
POSA - Overview: Posaconazole, Serum
Monitoring posaconazole therapy
PINW - Overview: Pinworm Exam, Perianal
Detection of the eggs of Enterobius vermicularis on the skin of the perianal folds
PFN - Overview: Propafenone, Serum
Monitoring propafenone therapy Assessing potential propafenone toxicity
Site Search
Visit Mayo Clinic Laboratories at Medlab Middle East 2023 - Insights
announce our participation in Medlab Middle East 2023, a medical conference and exhibition taking place in Dubai, United Arab Emirates, Feb. 6–9, 2023....
the American Academy of Neurology Annual Meeting 2023 - Insights
Clinic Laboratories is thrilled to participate in the American Academy of Neurology Annual Meeting 2023....
Register today for Classical Hematology 2023 - Insights
Taking place on October 3–4, 2023, in Rochester, Minnesota, the Classical Hematology 2023 conference focuses on addressing the evaluation of frequently encountered blood count abnormalities. The conference...
the American Academy of Neurology Annual Meeting 2023 - Insights
the American Academy of Neurology Annual Meeting, taking place in person in Boston on April 22–27, 2023....
Leveraging the Laboratory 2023 - Insights
Mayo Clinic Laboratories’ Outreach Conference was held Sept. 26-27, 2023, in Chicago. “Leveraging the Laboratory: Dimensions of Outreach” provides innovative views into all aspects of health system laboratory...